Peripheral leukocyte apoptosis in patients with parkinsonism: Correlation with clinical characteristics and neuroimaging findings

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Lin, Wei Che ^a   Tsai, Nai Wen ^a   Huang, Yung Cheng ^a   Cheng, Kuei Yueh ^a   Chen, Hsiu Ling ^a   Li, Shau Hsuan ^a   Kung, Chia Te ^a   Su, Yu Jih ^a   Lin, Wei Ming ^a   Chen, Meng Hsiang ^a   Chiu, Tsui Min ^a   Yang, I Hsiao ^a   Lu, Cheng Hsien ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BENSERAZIDE PLUS LEVODOPA; DOPAMINE; DOPAMINE TRANSPORTER; LEVODOPA; TECHNETIUM 99M;

ADULT; APOPTOSIS; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; PARKINSON DISEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AGED; BLOOD; BRAIN; COHORT ANALYSIS; CYTOLOGY; MIDDLE AGED; PARKINSONIAN DISORDERS; PATHOLOGY; PATHOPHYSIOLOGY;

AGED; APOPTOSIS; BRAIN; COHORT STUDIES; FEMALE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; NEUROIMAGING; PARKINSONIAN DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84899497653     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/635923     Document Type: Article

References (29)

1. Allam M. F., Del Castillo A. S., Fernández-Crehuet Navajas R., Parkinson's disease risk factors: genetic, environmental, or both? Neurological Research 2005 27 2 206 208 2-s2.0-15244344237 10.1179/016164105X22057 (Pubitemid 40388426)
2. MacHado A., Herrera A. J., Venero J. L., Santiago M., De Pablos R. M., Villarán R. F., Espinosa-Oliva A. M., Argüelles S., Sarmiento M., Delgado-Cortés M. J., Maurio R., Cano J., Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence. Parkinson's Disease 2011 2011 10 2-s2.0-79959256728 10.4061/2011/393769 393769
3. Hirsch E. C., Hunot S., Damier P., Faucheux B., Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Annals of Neurology 1998 44 3, supplement 1 S115 S120 2-s2.0-0031715925 (Pubitemid 28423837)
4. Hunot S., Boissière F., Faucheux B., Brugg B., Mouatt-Prigent A., Agid Y., Hirsch E. C., Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 1996 72 2 355 363 2-s2.0-0343844458 10.1016/0306-4522(95)00578-1 (Pubitemid 26111202)
5. Knott C., Stern G., Wilkin G. P., Inflammatory regulators in Parkinson's disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Molecular and Cellular Neuroscience 2000 16 6 724 739 2-s2.0-0034520395 10.1006/mcne.2000.0914 (Pubitemid 32062060)
6. Mogi M., Harada M., Riederer P., Narabayashi H., Fujita K., Nagatsu T., Tumor necrosis factor- α (TNF- α) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neuroscience Letters 1994 165 1-2 208 210 2-s2.0-0028178281 10.1016/0304-3940(94)90746-3 (Pubitemid 24043277)
7. Uematsu S., Mogi M., Deguchi T., Interleukin (IL)-1 β IL-6, tumor necrosis factor- α epidermal growth factor, and β 2-microglobulin levels are elevated in gingival crevicular fluid during human orthodontic tooth movement. Journal of Dental Research 1996 75 1 562 567 2-s2.0-0030307202 (Pubitemid 32770423)
8. Herrera A. J., Tomás-Camardiel M., Venero J. L., Cano J., Machado A., Inflammatory process as a determinant factor for the degeneration of substantia nigra dopaminergic neurons. Journal of Neural Transmission 2005 112 1 111 119 2-s2.0-12144269020 10.1007/s00702-004-0121-3 (Pubitemid 40104721)
9. Ji K.-A., Yang M.-S., Jeong H.-K., Min K.-J., Kang S.-H., Jou I., Joe E.-H., Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide-injected brain. GLIA 2007 55 15 1577 1588 2-s2.0-35048867410 10.1002/glia.20571 (Pubitemid 47556261)
10. Prigione A., Begni B., Galbussera A., Beretta S., Brighina L., Garofalo R., Andreoni S., Piolti R., Ferrarese C., Oxidative stress in peripheral blood mononuclear cells from patients with Parkinson's disease: negative correlation with levodopa dosage. Neurobiology of Disease 2006 23 1 36 43 2-s2.0-33745120510 10.1016/j.nbd.2006.01.013 (Pubitemid 43903629)
11. Petrozzi L., Lucetti C., Gambaccini G., Bernardini S., Del Dotto P., Migliore L., Scarpato R., Bonuccelli U., Cytogenetic analysis oxidative damage in lymphocytes of Parkinson's disease patients. Neurological Sciences 2001 22 1 83 84 2-s2.0-0035261642 10.1007/s100720170058 (Pubitemid 33622093)
12. Bas J., Calopa M., Mestre M., Molleví D. G., Cutillas B., Ambrosio S., Buendia E., Lymphocyte populations in Parkinson's disease and in rat models of Parkinsonism. Journal of Neuroimmunology 2001 113 1 146 152 2-s2.0-0035255035 10.1016/S0165-5728(00)00422-7 (Pubitemid 32008680)
13. Calopa M., Bas J., Callén A., Mestre M., Apoptosis of peripheral blood lymphocytes in Parkinson patients. Neurobiology of Disease 2010 38 1 1 7 2-s2.0-77549083834 10.1016/j.nbd.2009.12.017
14. Blandini F., Sinforiani E., Pacchetti C., Samuele A., Bazzini E., Zangaglia R., Nappi G., Martignoni E., Peripheral proteasome and caspase activity in Parkinson disease and Alzheimer disease. Neurology 2006 66 4 529 534 2-s2.0-33645013396 10.1212/01.wnl.0000198511.09968.b3 (Pubitemid 43739882)
15. Weng Y.-H., Yen T.-C., Chen M.-C., Kao P.-F., Tzen K.-Y., Chen R.-S., Wey S.-P., Ting G., Lu C.-S., Sensitivity and specificity of T c 99 m -TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects. Journal of Nuclear Medicine 2004 45 3 393 401 2-s2.0-2342579469 (Pubitemid 47618611)
16. Hwang W. J., Yao W. J., Wey S. P., Ting G., Reproducibility of T c 99 m -TRODAT-1 SPECT measurement of dopamine transporters in Parkinson's disease. Journal of Nuclear Medicine 2004 45 2 207 213 2-s2.0-1542609233 (Pubitemid 47618638)
17. Hughes A. J., Ben-Shlomo Y., Daniel S. E., Lees A. J., What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 1992 42 6 1142 1146 2-s2.0-0026629509
18. Ramaker C., Marinus J., Stiggelbout A. M., van Hilten B. J., Systematic evaluation of rating scales for impairment and disability in Parkinson's disease. Movement Disorders 2002 17 5 867 876 2-s2.0-0036765120 10.1002/mds.10248 (Pubitemid 36040991)
19. Goetz C. G., Poewe W., Rascol O., Sampaio C., Stebbins G. T., Counsell C., Giladi N., Holloway R. G., Moore C. G., Wenning G. K., Yahr M. D., Seidl L., Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Movement Disorders 2004 19 9 1020 1028 2-s2.0-4644321549 10.1002/mds.20213 (Pubitemid 39302834)
20. Schwab R. S., Engeland A., Projection Technique for Evaluating Surgery in Parkinson's Disease 1969 Edinburgh, UK E & S Livingstone
21. Tsai N.-W., Chang W.-N., Shaw C.-F., Jan C.-R., Lu C.-H., Leucocyte apoptosis in patients with acute ischaemic stroke. Clinical and Experimental Pharmacology and Physiology 2010 37 9 884 888 2-s2.0-77956050673 10.1111/j.1440-1681.2010.05398.x
22. Wesche D. E., Lomas-Neira J. L., Perl M., Chung C.-S., Ayala A., Leukocyte apoptosis and its significance in sepsis and shock. Journal of Leukocyte Biology 2005 78 2 325 337 2-s2.0-23044477087 10.1189/jlb.0105017 (Pubitemid 41061305)
23. Mangano E. N., Hayley S., Inflammatory priming of the substantia nigra influences the impact of later paraquat exposure: neuroimmune sensitization of neurodegeneration. Neurobiology of Aging 2009 30 9 1361 1378 2-s2.0-67650507572 10.1016/j.neurobiolaging.2007.11.020
24. Kung M.-P., Stevenson D. A., Plössl K., Meegalla S. K., Beckwith A., Essman W. D., Mu M., Lucki I., Kung H. F., T c 99 m TRODAT-1: a novel technetium-99m complex as a dopamine transporter imaging agent. European Journal of Nuclear Medicine 1997 24 4 372 380 2-s2.0-0030612044 10.1007/s002590050065 (Pubitemid 27183040)
25. Baba Y., Kuroiwa A., Uitti R. J., Wszolek Z. K., Yamada T., Alterations of T-lymphocyte populations in Parkinson disease. Parkinsonism and Related Disorders 2005 11 8 493 498 2-s2.0-27744603906 10.1016/j.parkreldis.2005.07.005 (Pubitemid 41627840)
26. Hirsch E. C., Hunot S., Neuroinflammation in Parkinson's disease: a target for neuroprotection? The Lancet Neurology 2009 8 4 382 397 2-s2.0-62549133546 10.1016/S1474-4422(09)70062-6
27. McGeer P. L., Itagaki S., Akiyama H., McGeer E. G., Rate of cell death in Parkinsonism indicates active neuropathological process. Annals of Neurology 1988 24 4 574 576 2-s2.0-0023740773
28. Bergquist J., Tarkowski A., Ekman R., Ewing A., Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proceedings of the National Academy of Sciences of the United States of America 1994 91 26 12912 12916 2-s2.0-0028606503 10.1073/pnas.91.26.12912
29. Carr L., Tucker A., Fernandez-Botran R., In vivo administration of L-dopa or dopamine decreases the number of splenic IFN γ -producing cells. Journal of Neuroimmunology 2003 137 1-2 87 93 2-s2.0-0037376646 10.1016/S0165-5728(03)00047-X (Pubitemid 36351569)